<DOC>
	<DOCNO>NCT02966275</DOCNO>
	<brief_summary>This study test automate hypoglycemia prevention treatment device ( glucagon-only bionic pancreas ) subject undergone post-bariatric surgery experience symptom hypoglycemia .</brief_summary>
	<brief_title>Post Bariatric Closed Loop Glucagon Trial</brief_title>
	<detailed_description />
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Age 21 year old gastric bypass 1 year . Postbariatric hypoglycemia prior episodes neuroglycopenia , unresponsive dietary intervention ( low glycemic index , control carbohydrate portion ) trial acarbose therapy maximally tolerate dose . Other therapy exclude subject long therapy continue study . Otherwise healthy ( mild chronic disease asthma , hypertension , depression allow well control ) . Selfreported frequency document hypoglycemia ( BG &lt; 60 mg/dl verify capillary blood glucose measurement ) least 2 time per week . Unable provide inform consent . Unable comply study procedure . Current participation another hypoglycemia relate clinical trial one primarily observational nature . Pregnancy ( positive urine HCG ) , breast feeding , plan become pregnant immediate future , sexually active without use contraception . Use insulin and/or insulin secretogues sulfonylurea , metglitides , glitazones . History cystic fibrosis , pancreatitis , type 1 diabetes pancreatic disease . End stage renal disease dialysis ( hemodialysis peritoneal dialysis ) . Any known liver biliary disease include cirrhosis , alcoholic liver disease , nonalcoholic fatty liver disease , nonalcoholic steatohepatitis , form viral hepatitis . Congestive heart failure ( establish history CHF , paroxysmal nocturnal dyspnea , orthopnea ) . Acute illness exacerbation chronic illness time study . Known insulinoma predominantly fast pattern hypoglycemia Adrenal insufficiency . Congenital hyperinsulinemia present hypoglycemia infancy . History pheochromocytoma . Fractionated metanephrines test patient history increase risk catecholamine secrete tumor : Paroxysms tachycardia , pallor , headache . Personal family history MEN 2A , MEN 2B , neurofibromatosis , von HippelLindau disease . Episodic treatment refractory ( require 4 medication achieve normotension ) hypertension . Untreated inadequately treated mental illness ( indicator would include symptoms psychosis , hallucination , mania , and/or psychiatric hospitalization last year ) . Current alcohol abuse ( intake average &gt; 3 drink daily last 30 day ) substance abuse ( use within last 6 month control substance without prescription ) . Unwilling unable refrain drink two drink hour four drink day trial . Electrically powered implant ( e.g . cochlear implant , neurostimulators ) might susceptible RF interference . History adverse reaction glucagon ( include allergy ) besides nausea vomiting . Unwilling unable completely avoid acetaminophen study period . Any factor , opinion principal investigator , would interfere safe completion study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>glucagon</keyword>
	<keyword>continuous glucose monitorering ( CGM )</keyword>
	<keyword>artificial pancreas</keyword>
	<keyword>hypoglycemia</keyword>
	<keyword>post-bariatric hypoglycemia</keyword>
	<keyword>bionic pancreas</keyword>
	<keyword>bariatric surgery</keyword>
</DOC>